Monsanto's Roundup Is Losing Ground, But It's Temporary
From a different point of view, the verdict against Monsanto's Roundup is a sad reminder that agricultural production cannot survive without chemicals (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 1, 2019 Category: Pharmaceuticals Authors: Yiannis Mouratidis, Contributor Source Type: news

Walgreens keeps on selling cigarettes despite criticism
Walgreens Boots Alliance Inc. will keep on selling cigarettes because, as the company's CEO says, "we ... have to do what our customers are requiring us to do." That's according to Walgreens (Nasdaq: WBA) CEO Stefano Pessina, who told The Wall Street Journal in a recent interview that "we see that when we don’t sell tobacco, we have a lot of [negative] reactions.” Pessina's comments come just a few weeks after the chief of the U.S. Food and Drug Admi nistration said he wants to sit down with… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 1, 2019 Category: Pharmaceuticals Authors: Ben Miller Source Type: news

AACR: Longer Survival With Gilteritinib in FLT3mut & #43; AML
MONDAY, April 1, 2019 -- For patients with FMS-like tyrosine kinase 3 (FLT3) mutations who have relapsed or refractory acute myeloid leukemia (AML), gilteritinib results in longer overall survival and higher response rates than salvage chemotherapy... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2019 Category: Pharmaceuticals Source Type: news

Discharge, Interhospital Transfer Varies With Insurance Status
MONDAY, April 1, 2019 -- Uninsured patients and Medicaid beneficiaries with acute pulmonary diseases have higher odds of interhospital transfer, according to a study published online April 1 in JAMA Internal Medicine. Arjun K. Venkatesh, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2019 Category: Pharmaceuticals Source Type: news

Awake Endoscopic Spinal Fusion Appears to Be Safe, Effective
MONDAY, April 1, 2019 -- Awake endoscopic minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) performed without general anesthesia is safe and seems effective for lumbar fusion, according to a study published online April 1 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2019 Category: Pharmaceuticals Source Type: news

Doctors Unclear on Legal Obligations in Caring for Patients With Disability
MONDAY, April 1, 2019 -- Practicing physicians might not understand their legal responsibilities when caring for people with disability, which may contribute to inequalities in their care, according to a study published online April 1 in Health... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2019 Category: Pharmaceuticals Source Type: news

FDA Approves Mavenclad for Treating Multiple Sclerosis
MONDAY, April 1, 2019 -- Mavenclad (cladribine) tablets were approved to treat adult patients with relapsing-remitting and active secondary progressive multiple sclerosis (MS) who have inadequately responded to or cannot tolerate an alternate drug... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2019 Category: Pharmaceuticals Source Type: news

The Human-Machine Matchup
Combining human reasoning with the machine learning functionality found in advanced analytics applications improves pharma processes (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - April 1, 2019 Category: Pharmaceuticals Source Type: news

Lawsuits Lay Bare Sackler Family ’ s Role in Opioid Crisis
Three generations of the Sackler family were deeply involved in running Purdue Pharma and knew of opioid abuse risks, according to lawsuits. (Source: NYT Health)
Source: NYT Health - April 1, 2019 Category: Consumer Health News Authors: DANNY HAKIM, RONI CARYN RABIN and WILLIAM K. RASHBAUM Tags: Opioids and Opiates Sackler Family Pain-Relieving Drugs Suits and Litigation (Civil) States (US) Drug Abuse and Traffic Buprenorphine (Drug) OxyContin (Drug) Attorneys General Purdue Pharma Massachusetts New York State Sackler, Art Source Type: news

Hearing Aid Startups Slash Prices By Following The Warby Parker Sales Model
Startups like Eargo and Audicus are trying to break into the market for hearing aids that's controlled by five manufacturers. Their pitch: lower costs by cutting out audiologists and storefronts, similar to how Warby Parker sells glasses online. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 1, 2019 Category: Pharmaceuticals Authors: Michela Tindera, Forbes Staff Source Type: news

Take Your Medicine: This $1.5 Billion Health Startup ’s Smart Pills Keep Patients From Forgetting
Are patients taking their medications correctly, and are the medicines working? A handful of digital health startups tries to make it easier to tell -- say, by embedding a tracking system into pills they swallow. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 1, 2019 Category: Pharmaceuticals Authors: Angel Au-Yeung, Forbes Staff Source Type: news

Better Diabetes Care: Healthcare Startups Say They ’ll Get Paid When Patients Get Better
So-called " value-based care " is a field ripe for startups, especially ones utilizing telemedicine and medical specialists who aren't doctors, like nurses and nutritionists. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 1, 2019 Category: Pharmaceuticals Authors: Ellie Kincaid, Forbes Staff Source Type: news

ExsoMed appoints William E. Maya as Chief Executive Officer
ALISO VIEJO, Calif., April 1, 2019 -- (Healthcare Sales & Marketing Network) -- ExsoMed, a surgical device company that develops innovative solutions for extremity procedures, announced today the appointment of William "Bill" E. Maya as new Chie... Devices, Orthopaedic, Personnel ExsoMed, ArcPhix, ArrowPhix, joint fusion (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 1, 2019 Category: Pharmaceuticals Source Type: news

Nexcelom Bioscience Launches the Cellaca(TM) MX at AACR
ATLANTA, April 1, 2019 -- (Healthcare Sales & Marketing Network) -- Nexcelom Bioscience, a leading provider of cell counting and characterization products for the life science industry, announced the launch of the revolutionary high throughput, high-speed... Diagnostics, Product Launch Nexcelom Bioscience, Cellaca MX, cell counter (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 1, 2019 Category: Pharmaceuticals Source Type: news

The Unseen And Unsung Hero Of Healthcare Is Software
Using internal software to improve communication between healthcare professionals means no more time wasted hunting down colleagues and hanging around in hallways. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 1, 2019 Category: Pharmaceuticals Authors: Nigel Davies, Contributor Source Type: news

Why We Must Use The Rome Statute To Prosecute Terrorists For Human Trafficking
The commission of the interlinked crimes of human trafficking, sexual violence, and terrorism is relatively new, encompassing a vicious cycle in which each crime effectively flows from the commission of the others. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 1, 2019 Category: Pharmaceuticals Authors: Nikita Malik, Contributor Source Type: news

' Newish' Artios Pharma snags former Lilly exec as CMO
Artios Pharma, a three-year-old DNA Damage Response biotech, developing a pipeline of cancer treatments, announced the appointment of Ian Smith, M.D., as Chief Medical Office. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - April 1, 2019 Category: Pharmaceuticals Source Type: news

Alphabet and Apple take divergent paths in health
Drug companies bet technology can revolutionise the $65bn market for clinical trials (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 1, 2019 Category: Pharmaceuticals Source Type: news

OncoSec Announces Advanced Therapy Medicinal Product Classification from the EMA for TAVO(TM) in Refractory Metastatic Melanoma
Classification as an ATMP Positions TAVO for Accelerated Review and Approval in Europe SAN DIEGO and PENNINGTON, N.J., April 1, 2019 -- (Healthcare Sales & Marketing Network) -- OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developin... Biopharmaceuticals, Oncology, Regulatory OncoSec Medical, TAVO , metastatic melanoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 1, 2019 Category: Pharmaceuticals Source Type: news

Audentes Therapeutics Appoints Legal and Corporate Communications Executives; Promotes Thomas P. Soloway to Executive Vice President and Chief Financial Officer
SAN FRANCISCO, April 1, 2019 -- (Healthcare Sales & Marketing Network) -- Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing innovative gene therapy products for patients living with serious, life... Biopharmaceuticals, Personnel Audentes Therapeutics, gene therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 1, 2019 Category: Pharmaceuticals Source Type: news

Artios Pharma Announces Appointment of Dr. Ian Smith as Chief Medical Officer
Establishes New Clinical Advisory Board of Leading Oncology Experts CAMBRIDGE, England, April 1, 2019 -- (Healthcare Sales & Marketing Network) -- Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company developing a broad pipeline o... Biopharmaceuticals, Oncology, Personnel Artios Pharma, DNA Damage Response (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 1, 2019 Category: Pharmaceuticals Source Type: news

Novartis to Acquire IFM Tre to Develop First-In-Class NLRP3 Antagonist Portfolio Targeting Innate Immune System
Acquisition of IFM Therapeutics subsidiary gives Novartis full rights to one clinical and two pre-clinical NLRP3 antagonist programs NLRP3 inhibition offers novel approach to preventing chronic inflammation that drives serious disease IFM to receive ... Biopharmaceuticals, Mergers & Acquisitions IFM Therapeutics, Novartis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 1, 2019 Category: Pharmaceuticals Source Type: news

Nasopharyngeal Microbiota Could Help Diagnose Pediatric LRTIs
MONDAY, April 1, 2019 -- Nasopharyngeal microbiota seem to serve as a valid proxy for lower respiratory tract microbiota in lower respiratory tract infections (LRTIs) among children, according to a study published online March 15 in The Lancet... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2019 Category: Pharmaceuticals Source Type: news

Meta-Analysis Links Shift Work to Risk for Ischemic Heart Disease
MONDAY, April 1, 2019 -- Shift work is associated with an increased risk for ischemic heart disease (IHD), with evidence of a positive dose-response relationship between the risk for IHD and increasing duration of shift work, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2019 Category: Pharmaceuticals Source Type: news

Liquid Meal Replacements Cut Cardiometabolic Risk Factors
MONDAY, April 1, 2019 -- Liquid meal replacements in weight loss diets lead to modest reductions in cardiometabolic risk factors for overweight and obese patients with type 2 diabetes, according to a review published online March 28 in Diabetes... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2019 Category: Pharmaceuticals Source Type: news

Increasing Dose for Total Body Irradiation Cuts Graft Failure
MONDAY, April 1, 2019 -- For patients with severe hemoglobinopathies undergoing bone marrow transplantation, increasing the dose of total body irradiation is associated with a reduction in graft failure, according to a study published in the April... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2019 Category: Pharmaceuticals Source Type: news

AACR: High BMI Before 50 Raising Pancreatic Cancer Mortality
MONDAY, April 1, 2019 -- Higher body mass index (BMI), especially before age 50, is associated with increased pancreatic cancer mortality, according to a study presented at the annual meeting of the American Association for Cancer Research, held... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2019 Category: Pharmaceuticals Source Type: news

Rates of CPR Before EMS Arrival Increased From 2000 to 2017
MONDAY, April 1, 2019 -- The rates of compression-only cardiopulmonary resuscitation (CO-CPR) and standard CPR (S-CPR) before arrival of emergency medical services (EMS) have increased and are associated with improved survival over no CPR (NO-CPR),... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2019 Category: Pharmaceuticals Source Type: news

Cannabis Products Used Differ for Cancer, Noncancer Patients
MONDAY, April 1, 2019 -- The forms of medical cannabis used vary for patients with and without cancer, according to a study published online March 25 in the Journal of Palliative Medicine. Arum Kim, M.D., from the New York University School of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2019 Category: Pharmaceuticals Source Type: news

Undiagnosed Gestational Diabetes Ups Risk for Stillbirth
MONDAY, April 1, 2019 -- Women at risk for gestational diabetes mellitus (GDM) who are not screened or diagnosed are more likely to experience stillbirth than women who undergo screening, according to a study published online March 19 in BJOG, an... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2019 Category: Pharmaceuticals Source Type: news

Vitamins, Carotenoids Associated With Lower Risk for Cataract
MONDAY, April 1, 2019 -- Higher consumption of certain vitamins and carotenoids is associated with a significantly decreased risk for age-related cataract (ARC) in cohort studies, according to a meta-analysis published in the January issue of The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2019 Category: Pharmaceuticals Source Type: news

Changes to WIC Food Program Tied to Reversal in Obesity Trends
MONDAY, April 1, 2019 -- The 2009 changes to the U.S. Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) was associated with a change in the trend of obesity prevalence among 2- to 4-year-old children, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2019 Category: Pharmaceuticals Source Type: news

Britain's Version Of'Medicare For All' Is Collapsing
Long waits for care are endemic to government-run, single-payer systems like the NHS. Yet some U.S. lawmakers want to import that model from across the pond. That would be a massive blunder. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 1, 2019 Category: Pharmaceuticals Authors: Sally Pipes, Contributor Source Type: news

Highly Profitable Medical Journal Says Open Access Publishing Has Failed. Right.
The New England Journal of Medicine just published an editorial saying open access publishing isn't necessary, because they already make most of their content free. What are they so worried about? Yours truly breaks down a few of their bogus arguments. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 1, 2019 Category: Pharmaceuticals Authors: Steven Salzberg, Contributor Source Type: news

Sharing An Innate Desire To Address Inflammation: Novartis And IFM Team Up
Today Novartis announced the acquisition of IFM Therapeutics ’ portfolio of NLRP3 antagonists, via the purchase of IFM Tre, a subsidiary of IFM (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 1, 2019 Category: Pharmaceuticals Authors: Bruce Booth, Contributor Source Type: news

The next key trend in mental health is resilience: Meet eQuoo, The Emotional Fitness Game
One of the key trends in the mental health space is now on boosting resilience; the key factor proven to reduce the likelihood of developing mental health issues. Meet eQuoo, The Emotional Fitness Game which is proving to boost resilience through gaming. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 1, 2019 Category: Pharmaceuticals Authors: Serena Oppenheim, Contributor Source Type: news

AveXis expands world-leading gene therapy manufacturing capacity with purchase of advanced biologics therapy manufacturing campus in Longmont, Colorado
AveXis, a Novartis company, today announced it signed an agreement to purchase an advanced biologics therapy manufacturing campus in Longmont, Colorado, further expanding AveXis' production capacity as it prepares to launch Zolgensma® (onasemnogene abeparvovec-xioi[1]) an investigational gene therapy awaiting global regulatory approvals for the treatment of spinal muscular atrophy (SMA) Type 1 and for future gene therapy treatments in development. (Source: World Pharma News)
Source: World Pharma News - April 1, 2019 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news

Invitation to Roche's live audio webcast on data presented at AAN 2019 - 13 May 2019
We are pleased to invite investors and analysts to participate in a live audio webcast and conference call on Monday, 13 May 2019, highlighting Roche data presented at the American Academy of Neurology (AAN) Annual Meeting (4-10 May 2019) in Philadelphia, United States. (Source: Roche Investor Update)
Source: Roche Investor Update - April 1, 2019 Category: Pharmaceuticals Source Type: news

Sugar could be sweet solution to respiratory disease
Restriction or inhalation of common sugar could one day treat a range of respiratory diseases, according to new research led by University of Manchester biologists. The study in mice reveals how the ability of cells to use glucose helps to regulate the immune system during lung inflammation. (Source: World Pharma News)
Source: World Pharma News - April 1, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Addiction and work: One mother ’s story
Though I don ’t suffer from addiction myself, it controlled my life for years. As a loved one, I felt the effects of the disease in profound ways. It severely impacted my mental and physical health as well as my ability to perform at work. My son’s addiction influenced my day-to-day work for about three yea rs. When his disease was at its worst, my typical work day was marred by worry, stress and sleep deprivation. I was constantly making and receiving calls — usually trying to ensure he’d… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 1, 2019 Category: Pharmaceuticals Authors: Kristen Goettsch Source Type: news

FDA Approves the Reintroduction of Zelnorm (tegaserod) for Irritable Bowel Syndrome with Constipation (IBS-C) in Women Under 65
LOUISVILLE, Ken., April 1, 2019 /PRNewswire/ -- US WorldMeds has announced that Sloan Pharma, S.a.r.l., a subsidiary of US WorldMeds Holdings, LLC, has received approval from the U.S. Food and Drug Administration (FDA) for the reintroduction of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 1, 2019 Category: Drugs & Pharmacology Source Type: news

8 ways addiction is affecting your workplace
With the worsening opioid crisis, addiction is a growing challenge in every industry. More than 70 percent of people with addiction are employed either part or full time. But because of the nature of this disease, and the shame that comes with it, many suffer in silence. “Although many don’t realize it, employers bear the brunt of the cost of addiction due to higher health care costs, more turnover and increased absenteeism, among other things. The good news i s that employers have more tools… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 1, 2019 Category: Pharmaceuticals Authors: Ally Krupinsky Source Type: news

Hedgehogs And Salmonella: What Is The Latest From The CDC
Add 6 more people and 3 new states to the list of those affected by the outbreak. That brings the total to 17 reported cases in 11 states with 2 hospitalizations. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 1, 2019 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Novartis scoops up IFM immunotherapy subsidiary for $310 million
Pharmaceutical giant Novartis will pay $310 million to purchase an Atlas Venture-backed Boston startup focused on treatments using the body's immune system. Novartis (NYSE: NVS) has signed a deal to purchase pre-commercial company IFM Tre. Another $1.27 billion will be available in milestone payments, bringing the deal total to nearly $1.6 billion, according to a press release. IFM Tre launched in July 2018 with plans to develop therapies for inflam matory diseases that block the production of… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 1, 2019 Category: Pharmaceuticals Authors: Allison DeAngelis Source Type: news

The Rise of Genetic Testing Companies and DNA Data Race
With the rise of direct to consumer (DTC) genetic testing companies, and an explosion of genomic data emerging from individual DNA, genome companies are racing to build a search engine for our DNA. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 1, 2019 Category: Pharmaceuticals Authors: Jayshree Pandya, Contributor Source Type: news

Roche ’s ipatasertib in combination with Tecentriq and chemotherapy shows promising anti-tumour activity in triple-negative breast cancer in early phase trial
Roche will today present the initial results from a Phase Ib study evaluating the efficacy and safety for the combination of ipatasertib, Tecentriq ® (atezolizumab) and chemotherapy (paclitaxel or nab-paclitaxel (Abraxane® [paclitaxel albumin-bound particles for injectable suspension]) as a first-line treatment option for people with advanced triple-negative breast cancer (TNBC). (Source: Roche Media News)
Source: Roche Media News - April 1, 2019 Category: Pharmaceuticals Source Type: news

Roche ’s ipatasertib in combination with Tecentriq and chemotherapy shows promising anti-tumour activity in triple-negative breast cancer in early phase trial
Roche will today present the initial results from a Phase Ib study evaluating the efficacy and safety for the combination of ipatasertib, Tecentriq ® (atezolizumab) and chemotherapy (paclitaxel or nab-paclitaxel (Abraxane® [paclitaxel albumin-bound particles for injectable suspension]) as a first-line treatment option for people with advanced triple-negative breast cancer (TNBC). (Source: Roche Investor Update)
Source: Roche Investor Update - April 1, 2019 Category: Pharmaceuticals Source Type: news

Here's How Much Chiropractors Earn In Every State
Chiropractors don't make the same amount in every state, so find out which ones pay the best. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 1, 2019 Category: Pharmaceuticals Authors: Andrew DePietro, Contributor Source Type: news

March 2019 Briefing
Here are what the editors at HealthDay consider to be the most important developments in Family Practice for March 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2019 Category: Pharmaceuticals Source Type: news

Outstanding Women in Business 2019: Mary Frances Blackburn
Blackburn endorses the philosophy of the nation's first female four-star general: "Exceed the standards and try to make a difference every day," (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 1, 2019 Category: Pharmaceuticals Source Type: news